Featured Publications
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
Lind M, Dorion M, Houde A, Lansing M, Lapidus S, Thomas R, Yildirim I, Omer S, Schulz W, Andrews J, Hitchings M, Kennedy B, Richeson R, Cummings D, Ko A. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population. Nature Communications 2023, 14: 5055. PMID: 37598213, PMCID: PMC10439918, DOI: 10.1038/s41467-023-40750-8.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionPrior infectionHybrid immunityInfection riskCOVID-19 vaccinationNon-pharmaceutical interventionsInfected residentsVaccinationInfectionDocumented exposureDelta periodCell exposureIncarcerated populationsExposureImmunityRiskAssociationPotential benefitsCorrectional facilitiesCrowded settingsResidentsPeriod
2021
COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates
AlKetbi LMB, Elharake JA, Memari SA, Mazrouei SA, Shehhi BA, Malik AA, McFadden SM, Galal B, Yildirim I, Khoshnood K, Omer SB, Memish ZA, AlZarouni AA, AlNeyadi AM, Hosani FA. COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates. IJID Regions 2021, 1: 20-26. PMID: 35721775, PMCID: PMC8505903, DOI: 10.1016/j.ijregi.2021.08.003.Peer-Reviewed Original ResearchCOVID-19 vaccine acceptanceVaccine acceptanceHealthcare workersCOVID-19 vaccineHCW populationVaccine hesitancyCOVID-19 vaccine informationPublic health messaging campaignsCOVID-19 vaccine concernsCOVID-19 vaccine hesitancyYears of agePhysicians/surgeonsWorld Health OrganizationSimple logistic regressionVaccine informationVaccine concernsGeneral populationPatient decisionHealthcare providersInfection riskLogistic regressionHealthcare authoritiesHealth officialsHealth OrganizationVaccineRisk of Disseminated Gonococcal Infections With Terminal Complement Blockade
Graciaa SH, Graciaa DS, Yildirim I, Chonat S. Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade. Journal Of Pediatric Hematology/Oncology 2021, 44: e493-e495. PMID: 33560079, PMCID: PMC8556643, DOI: 10.1097/mph.0000000000002075.Peer-Reviewed Original ResearchConceptsTerminal complement blockadeComplement blockadeGonococcal infectionClonal hematopoietic stem cell disordersDisseminated gonococcal infectionHematopoietic stem cell disordersQuality of lifeStem cell disordersParoxysmal nocturnal hemoglobinuriaComplement protein C5Complement-mediated hemolysisProphylactic antibioticsIntravascular hemolysisAppropriate immunizationsAzithromycin resistanceCell disordersNocturnal hemoglobinuriaNeisseria gonorrhoeaeProtein C5Infection riskPatientsMonoclonal antibodiesNeisseria meningitidisBlockadeInfection